Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus propofol dosing for painless gastroscopy
ChiCTR2000038599Phase 4Not yet recruiting
- Sponsor
- Nanchong City Central Hospital
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine and propofol in Anxiety Disorder Due To Another Medical Condition (4 arms), sponsored by Nanchong City Central Hospital. Primary endpoints: Modified Aldrete score, VAS pain score and 8 more. Planned start Sep 2020; status: not yet recruiting.
02
Drugs
esketaminepropofol
03
Conditions
Anxiety Disorder Due To Another Medical Condition
Beyond the preview
Go deeper on ChiCTR2000038599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038599.